Triple Drug Therapy with Proton Pump Inhibitor a Better Option for Helicobacter Pylori Eradication.

H.Pylori is a gram-negative micro organism residing in the stomach of human. It is a important cause of acid peptic disorders. Bismuth based triple therapy,triple therapy regimens (Tripple PPI) and Quadruple therapy are the available treatment options to eradicate H. pylori. Controversy still presen...

Descripción completa

Detalles Bibliográficos
Publicado en:Medico-Legal Update Vol. 20; no. 4; pp. 1252 - 1257
Autores principales: R., Lamture Y., Dihare, Thavendra Jaglal, Gajbhiye, Varsha, Dilip, Gode
Formato: clinical trial research tables/charts Journal Article
Publicado: Institute of Medico-legal publications Pvt Ltd Oct-Dec2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=162449591&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 162449591
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0971720X
        6CKZ
      jtl: Medico-Legal Update
      issn: 0971720X
      maglogo: N
    pubinfo:
      dt: Oct-Dec2020
      vid: 20
      iid: 4
      pid: 50801
      pub: Institute of Medico-legal publications Pvt Ltd
    artinfo:
      ui:
        162449591
        162449591
        162449591
        10.37506/mlu.v20i4.1999
        162449591
      ppf: 1252
      ppct: 5
      formats:
      tig:
        atl: Triple Drug Therapy with Proton Pump Inhibitor a Better Option for Helicobacter Pylori Eradication.
      aug:
        au:
          R., Lamture Y.
          Dihare, Thavendra Jaglal
          Gajbhiye, Varsha
          Dilip, Gode
        affil: Professor in Surgery, J.N. Medical college Wardha
      sug:
        subj:
          Drug Therapy, Combination Methods
          Proton Pump Inhibitors Therapeutic Use
          Helicobacter Infections Drug Therapy
          Helicobacter Infections Prevention and Control
          Human
          India
          Clinical Trials
          Prospective Studies
          Male
          Female
          Young Adult
          Adult
          Middle Age
          Signs and Symptoms Complications
          Hemostasis, Endoscopic
          Duodenal Ulcer
          Peptic Ulcer
          Bismuth
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
          Female
      ab: H.Pylori is a gram-negative micro organism residing in the stomach of human. It is a important cause of acid peptic disorders. Bismuth based triple therapy,triple therapy regimens (Tripple PPI) and Quadruple therapy are the available treatment options to eradicate H. pylori. Controversy still presents regarding the superiority of treatment modality and results of available studies are variable. Hence this study was undertaken to evaluate and compare the efficacy of triple PPI, Quadruple therapy, and bismuth-based triple therapy in treating acid peptic disorders and Helicobacter pylori eradication. Method: This study was a prospective interventional. After the establishment of a clinical diagnosis of the acid peptic disorder, the patient was posted for endoscopy. H. pylori status was determined by the rapid urease test and culture examination. All patients divided into three groups and offered three different medical treatments the first group received bismuth bases triple therapy, the second group got Tripple PPI therapy and the third one received quadruple therapy. efficacy and comparison of all these treatment modalities were evaluated and assessed by symptoms, endoscopic findings, and results of the rapid urease test after 6 weeks. Results: In the present study, 150 patients with upper gastrointestinal symptoms were studied It was found that the maximum number of subjects belonged to the age group 31-40 yrs. Male outnumbers than females. Maximum patients had pain in epigastric region and were having gastritis as a commonest diagnosis., Symptomatic relief by Triple therapy with PPI was maximum than other therapies. Rapid urease test (RUT) was also suggest that treatment with it gives superior eradication rates. Discussion: In our study, we have found that the treatment regime with PPI Triple therapy has given maximum symptomatic relief, there is an association of H. Pylori infection in an acid peptic disorder like duodenal ulcer (86.66%), gastric ulcer (75%), and gastritis (82.85%). the efficacy of the Rapid urease test is 66% and that of culture is 38.66% in the diagnosis of H. pylori infection in acid peptic disorder. Conclusion: PPI Triple therapy is most effective in symptomatic relief and healing of the duodenal and peptic ulcer.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N